Retrospective Study
Copyright ©The Author(s) 2022.
World J Clin Cases. Oct 16, 2022; 10(29): 10451-10466
Published online Oct 16, 2022. doi: 10.12998/wjcc.v10.i29.10451
Table 4 Analysis of survival and prognosis of patients with advanced gastric cancer
Variable
OS (AGC = 3895), or (95%CI)
P value
OS (SRC = 1013), or (95%CI)
P value
Age (yr)< 0.001< 0.001
< 401 (Reference)1 (Reference)
40-601.130 (0.882-1.447)0.3331.267 (0.898-1.788)0.178
60-801.543 (1.212-1.985)< 0.0011.578 (1.123-2.218)0.009
> 802.936 (2.281-3.780)< 0.0012.290 (1.528-3.431)< 0.001
Race< 0.001< 0.001
White1 (Reference)1 (Reference)
Black1.096 (0.973-1.234)0.1331.326 (1.057-1.663)0.015
Black-AI1.382 (0.949-2.015)0.0922.624 (1.423-4.838)0.002
Black-API0.726 (0.651-0.810)< 0.0010.800 (0.867-1.205)0.041
Sex
Male1 (Reference)1(Reference)
Female0.964 (0.883-1.052)0.4091.022 (0.867-1.205)0.791
Tumor size (cm)< 0.0010.001
< 21 (Reference)1 (Reference)
2-51.026 (0.823-1.280)0.8171.031 (0.680-1.565)0.885
> 51.211 (0.971-1.511)0.0891.415 (0.930-2.152)0.105
AJCC stage0.0190.028
I1 (Reference)1 (Reference)
II1.227 (0.903-1.667)0.1911.946 (0.923-4.102)0.080
III1.584 (1.076-2.330)0.0203.050 (1.247-7.458)0.015
T stage< 0.001< 0.001
T21 (Reference)1 (Reference)
T31.384 (1.135-1.689)0.0011.857 (1.189-2.899)0.006
T42.025 (1.633-2.512)< 0.0012.615 (1.644-4.161)< 0.001
N stage< 0.0010.086
N01 (Reference)1 (Reference)
N11.241 (1.056-1.459)0.0091.061 (0.744-1.512)0.745
N21.295 (1.050-1.597)0.0161.034 (0.665-1.608)0.881
N31.904 (1.549-2.341)< 0.0011.341 (0.882-2.037)0.170
Histology0.002
Differentiated1 (Reference)
SRC1.276 (1.117-1.458)< 0.001
Undifferentiated1.164 (1.037-1.306)0.010
SRC vs non-SRC1.139 (1.030-1.258)0.011
Adjuvant therapy< 0.001
Radiotherapy0.635 (0.367-1.099)0.105
Chemotherapy0.481 (0.388-0.595)< 0.001
Radiotherapy + Chemotherapy0.414 (0.334-0.512)< 0.001
None1 (Reference)